Drug Interaction Between Co-packaged Nirmatrelvir-ritonavir and Tacrolimus might cause Hyponatremia and Tacrolimus Intoxication in Lung Transplant Recipients

Chien-Ming Lo,Wei‐Hsun Chen,Meng-Yun Tsai,Hung-I Lu, Yen-Che Hsiao,Yu Chen,Hsuan-Feng Wu,Kuo‐Tung Huang,Yi‐Hsi Wang

Research Square (Research Square)（2023）

引用 0|浏览4

暂无评分

摘要

Abstract COVID-19 infection in recipients of lung transplants could be lethal owing to the immunosuppressant agents. Antiviral agents should be administered to these patients. Co-packaged nirmatrelvir-ritonavir is a new agent that is used in combination with antiviral medications. Here, we report a case of high serum tacrolimus concentration and hyponatremia after co-packaged nirmatrelvir-ritonavir administration.

查看译文

关键词

tacrolimus intoxication,hyponatremia,co-packaged,nirmatrelvir-ritonavir

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要